Tuberculosis: an overview

How to Protect Ourselves from TB - Advocacy roadmap TB Preventive Treatment Through Community Engagement : Virtual and In-person Workshop
Launch of How to Protect Ourselves from TB Community Friendly Brochure on TB Preventive Therapy in 9 Languages
Launch of Men and Stigma Book at the 50th Union Conference
Launch of Transforming the TB Response - Capacity Building of Communities to be Change Agents Training Manual at the 50th Union Conference
Capacity Building Workshop for TB Survivors in India
Capacity Building Workshop in Dili, Timor-Leste organized in collaboration with WHO Timor-Leste Country Office
Civil Society Task Force with Director General WHO Dr.Tedros at the Strategic and Technical Advisory Group Meeting June, 2019
CEO, GCTA at the Meeting of the Regional Stakeholder's Consultation on Tools for Community Engagement for MDR-TB Services (Dhaka,Bangladesh)
CEO,GCTA at the Integrating Mental Health Services into Standard of TB Care Meeting
TB-HIV-and-Malaria-Activists-Training-on-Domestic-Financing-in-India
Launch of GCTA Human Rights Policy Brief by Dr. Tedros
GCTA launches book on Women and Stigma at the UN Interactive Civil Society Hearing in New York - June 2018
Capacity-Building Workshop for TB Advocates in North-East India
Civil Society Advisory Group with Dr Tedros Adhanom, Director General-WHO, at the Global Ministerial Conference - November 2017
GCTA Board Member Elvi Siahaan at the Launch of TB Stigma Assessment Tool and Right to Breathe Training Manual
GCTA Facilitated the Formation of Touched by TB - India’s First National Coalition of People Affected by TB – At the 2 nd National Meeting in July, 2017
Members of Civil Society and Communities interact with Eric Goosby, United Nations Special Envoy on Tuberculosis - August, 2017
GCTA Community
GCTA Community
GCTA Community

Tuberculosis remains one of the leading causes of death with an estimated 9 million new cases every year. In 2011, 1.4 million people died from TB, including almost one million deaths among HIV-negative individuals and 430 000 among people who were HIV-positive. TB is one of the top killers of women, with 300 000 deaths among HIV-negative women and 200 000 deaths among HIV-positive women in 2011.

There have been remarkable achievements in the past decade. The MDG target for halting the incidence of TB is on track and prevalence and mortality are falling slowly.

Yet without dramatic increases in funding and political commitment between now and 2015:

Over 50 million people will develop active TB disease
Over 10 million lives will be lost to this preventable, curable disease; over 4 million of them will be women.
Over 2 million cases of multidrug-resistant TB will emerge for want of proper care
Millions of children will be orphaned needlessly.
There is current global shortfall of nearly US$ 3 billion per year to fight TB1

Experience throughout the world has proved that where TB patients, activists and communities are actively involved in TB prevention and care efforts, research, crucial issues of new case detection, community health services, regulatory affairs and provision of timely services, are addressed effectively. However, unlike the HIV/AIDS community, the engagement of TB affected community is very limited at the global, regional and national levels.

To bridge this gap, as well as to ensure continuity from the Community Task Force and to evolve to the next level based on the current realities, needs and challenges, the Global Coalition of TB Advocates (GCTA) was created.

Tuberculosis: an overview

NEWS AND EVENTS

Our Partners